Melacare Cream (Hydroquinone/Tretinoin/Mometasone)
Price range: 28.00$ through 61.00$
Product Overview Melacare Cream is a prescription‑only topical formulation that combines three well‑established dermatological agents—hydroquinone, tretinoin, and mometasone—into a single 20 gram tube. The product is manufactured by Ajanta Pharma Ltd
| Pack Size | Price | Quantity | |
|---|---|---|---|
| 1 Cream | 28.00$ | ||
| 3 Cream/s | 41.00$ | ||
| 6 Cream/s | 61.00$ |
Product Overview
Melacare Cream is a prescription‑only topical formulation that combines three well‑established dermatological agents—hydroquinone, tretinoin, and mometasone—into a single 20 gram tube. The product is manufactured by Ajanta Pharma Ltd and is specifically indicated for the treatment of melasma, a chronic skin condition characterized by symmetric hyperpigmentation on the face. The combination leverages the lightening power of hydroquinone, the epidermal turnover‑accelerating effect of tretinoin, and the anti‑inflammatory potency of mometasone to provide a multifaceted approach to pigment reduction and skin texture improvement. Pack size options include single‑cream, three‑cream, and six‑cream bundles, allowing patients to select a regimen that matches their treatment plan while maintaining consistent therapeutic coverage. National Institutes of Health
What is Melacare Cream
Melacare Cream belongs to the class of topical dermatologic medications used in the management of melasma and other hyperpigmentary disorders. Its triple‑action composition distinguishes it from single‑ingredient products, as each component addresses a different pathogenic mechanism: hydroquinone inhibits melanin synthesis, tretinoin promotes rapid keratinocyte turnover, and mometasone dampens localized inflammation that can exacerbate pigmentation. The cream is supplied in a 20 gram tube, which is intended for external use only and should be kept away from the eyes, lips, and mucous membranes. Because the formulation contains a prescription‑strength corticosteroid, it is classified as a regulated pharmaceutical product and should be obtained only through licensed healthcare providers or authorized online pharmacies. U.S. Food and Drug Administration
Uses and Benefits
The primary indication for Melacare Cream is melasma, a condition that often recurs despite sunscreen use and can be resistant to monotherapy. Clinical studies have demonstrated that the synergistic combination yields faster and more pronounced lightening of melasma patches compared with any of the individual agents used alone. Patients typically experience a reduction in the intensity of brown or gray‑brown patches within weeks, along with improved skin smoothness due to tretinoin’s exfoliating action. The anti‑inflammatory component helps prevent post‑inflammatory hyperpigmentation, a common side effect of aggressive pigment‑lightening therapies. In addition to melasma, prescribers may consider the cream for post‑procedure hyperpigmentation following laser or dermabrasion, provided that the treating clinician evaluates suitability on a case‑by‑case basis. MedlinePlus
How It Works
Understanding the mechanism of action clarifies why the triple combination is effective. Hydroquinone blocks the enzyme tyrosinase, which is essential for melanin production, thereby decreasing the amount of pigment formed in the epidermis. Tretinoin, a retinoic acid derivative, binds to retinoid receptors in skin cells, accelerating the shedding of pigmented keratinocytes and stimulating collagen remodeling that supports a more even skin surface. Mometasone, a synthetic glucocorticoid, reduces inflammation by inhibiting the release of prostaglandins and cytokines that can otherwise trigger melanocyte activation. Together, these pathways create a balanced environment where pigment synthesis is curtailed, pigmented cells are removed more rapidly, and inflammatory triggers are attenuated, resulting in a progressive fade of melasma lesions. U.S. Food and Drug Administration
Dosage Guidelines
Melacare Cream should be applied exactly as directed by a qualified healthcare professional. The typical regimen involves a thin layer of cream spread over the affected facial areas once daily, preferably in the evening to minimize exposure to direct sunlight. Patients are advised to wash their hands before and after application and to avoid applying the product to unaffected skin, as unnecessary use may increase the risk of irritation. Because the formulation contains a prescription‑strength corticosteroid, prolonged use without medical supervision is discouraged. If a dose is missed, the patient should simply resume the regular schedule; double application to compensate for a missed dose is not recommended. Ongoing monitoring by a dermatologist is essential to assess response, adjust treatment duration, and determine when to discontinue or taper therapy.
Side Effects
Like all prescription topical agents, Melacare Cream may produce adverse reactions, although many users experience only mild, transient effects. Common side effects include localized erythema, itching, burning, or a sensation of warmth at the application site. Some individuals may notice dryness, peeling, or mild contact dermatitis as the skin adjusts to tretinoin and hydroquinone. Although rare, more serious reactions such as severe allergic dermatitis, facial swelling, or signs of systemic corticosteroid absorption (e.g., weight gain, hypertension) warrant immediate medical attention. Patients should discontinue use and contact a healthcare provider if they develop blistering, intense pain, or any indication of an allergic response. National Institutes of Health
Warnings and Precautions
Before initiating therapy with Melacare Cream, a thorough medical history should be reviewed to identify contraindications and risk factors. The product is contraindicated in patients with known hypersensitivity to any of its components, as well as in those with active viral infections, severe acne, or rosacea that could be exacerbated by steroid use. Because hydroquinone has been associated with ochronosis when used in excessive concentrations or over long periods, therapy should be limited to the shortest duration necessary to achieve desired results. Pregnant or breastfeeding women should avoid this medication unless a physician determines that the benefits outweigh potential risks. Patients are reminded to use adequate sun protection, as ultraviolet exposure can undermine treatment efficacy and precipitate rebound pigmentation. Finally, concurrent use of other over‑the‑counter skin‑lightening products should be discussed with a dermatologist to prevent additive irritation or unintended interactions. MedlinePlus
Frequently Asked Questions
Is Melacare Cream safe for daily use?
When used exactly as prescribed by a licensed dermatologist, the cream can be applied daily for a limited treatment period. However, long‑term daily application is not recommended without medical oversight due to the presence of hydroquinone and a corticosteroid.
Can I purchase Melacare Cream without a prescription?
No. Because the formulation contains prescription‑strength ingredients, a valid prescription from a qualified healthcare provider is required before dispensing the product.
How long does it take to see results?
Most patients notice a visible lightening of melasma patches after 4‑6 weeks of consistent use, though individual response times vary based on pigment depth and adherence to the regimen.
Are there any dietary restrictions while using this cream?
No specific dietary restrictions are associated with topical use, but maintaining a balanced diet rich in antioxidants may support overall skin health during treatment.
What should I do if I experience severe irritation?
Discontinue application immediately and seek medical advice. Severe irritation may require topical steroids or other supportive care under a physician’s guidance.
Is long‑term use of Melacare Cream recommended?
Long‑term continuous use is generally not advised; treatment should be limited to the duration prescribed by a healthcare professional, typically ranging from several weeks to a few months, depending on response and tolerance.
Related Products
- Magnalyte Cream (Flucinolone Acetonide/Hydroquinone/Tretinoin)
- Ajanta ED Trial Pack (Sildenafil/Tadalafil/Vardenafil)ED Trial Pack
- Ivrea Cream (Ivermectin)
- Magnalyte Cream 15gm (Flucinolone Acetonide/Hydroquinone/Tretinoin)
- Magnalyte Plus Cream (Flucinolone Acetonide/Hydroquinone/Tretinoin)
- Melalong AD Cream (Mequinol/Tretinoin)
- Skinlite Cream (Hydroquinone/Tretinoin/Mometasone)
- Skinshine Cream (Hydroquinone/Tretinoin/Mometasone)
- Apcalis oral Jelly 20mg
- Kamagra Gold 100 mg (Sildenafil Citrate)
- Kamagra 100 mg (Sildenafil Citrate)
- Kamagra Chewable 100mg (Sildenafil Citrate)
Related Products
In stock
Reviews
There are no reviews yet.